Immune responses of Elk to initial and booster vaccinations with Brucella abortus strain RB51 or 19

Clinical and Vaccine Immunology

Volumn 13, Issue 10, 2006, Pages 1098-1103

  Olsen, S C ^a   Fach, S J ^a   Palmer, M V ^a   Sacco, R E ^a   Stoffregen, W C ^a   Waters, W R ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BACTERIAL ANTIGEN; BACTERIAL VACCINE; DORAMECTIN; GAMMA INTERFERON; ULTRABAC 7;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BRUCELLA ABORTUS; BRUCELLOSIS; BUFFALO; CATTLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RED DEER; SERODIAGNOSIS; STRAIN DIFFERENCE; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ANIMALS; BACTERIAL VACCINES; BRUCELLA ABORTUS; BRUCELLOSIS; CELLS, CULTURED; DEER; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNIZATION, SECONDARY;

EID: 33750309621     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00213-06     Document Type: Article

References (29)

1. Araya, L. N., P. H. Elzer., G. E. Rowe, F. M. Enright, and A. J. Winter. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 143:3330-3337.
2. Cheville, N. F., S. C. Olsen, A. E. Jensen, M. G. Stevens, and M. V. Palmer. 1996. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. Am. J. Vet. Res. 57:1153-1156.
3. Claus, D., S. Kilpatrick, R. Dean, and B. Smith. 2002. Brucellosis-feedground-habitat program: an integrated management approach to brucellosis in elk in Wyoming, p. 80-96. In T. J. Kreeger (ed.), Proceedings of Brucellosis in Elk and Bison in the Greater Yellowstone Area. Wyoming Game and Fish Department, Cheyenne, Wyo.
4. Fernandes, D., and C. Baldwin. 1995. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect. Immun. 63:1130-1133.
5. Herriges, J. D., E. T. Thorne, S. L. Anderson, and H. A. Dawson. 1989. Vaccination of elk in Wyoming with reduced dose strain 19 Brucella: controlled studies and ballistic implant field trials. Proc. U. S. Anim. Health Assoc. 93:640-655.
6. Kreeger, T. J., M. W. Miller, M. Wild, P. H. Elzer, and S. C. Olsen. 2000. Safety and efficacy of Brucella abortus strain RB51 vaccine in captive pregnant elk. J. Wildl. Dis. 36:477-483.
7. Kreeger, T. J., W. E. Cook, W. H. Edwards, P. H. Elzer, and S. C. Olsen. 2002. Brucella abortus strain RB51 vaccination in elk II. Failure of high dosage to prevent abortion. J. Wildl. Dis. 38:27-31.
8. Kreeger, T. J., and S. C. Olsen. 2002. Brucellosis vaccination in elk, p. 43-50. In T. J. Kreeger (ed.), Proceedings of Brucellosis in Elk and Bison in the Greater Yellowstone Area. Wyoming Game and Fish Department, Cheyenne, Wyo.
9. Lee, I.-K., S. C. Olsen, and C. A. Bolin. 2001. Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model. Can. J. Vet. Res. 65:223-228.
10. Montaraz, J. A., and A. J. Winter. 1986. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 53:245-251.
11. Montaraz, J. A., A. J. Winter, D. M. Hunter, B. A. Sowa, A. M. Wu, and L. G. Adams. 1986. Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies. Infect. Immun. 51:961-963.
12. Morel, P. A., and T. B. Oriss. 1998. Crossregulation between Th1 and Th2 cells. Crit. Rev. Immunol. 18:275-303.
13. Murphy, E. A., J. Sathiyaseelan, M. A. Parent, B. Zou, and C. L. Baldwin. 2001. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103:511-518.
14. Nonnecke, B. J., W. R. Waters, M. R. Foote, M. V. Palmer, B. L. Miller, T. E. Johnson, H. B. Perry, and M. A. Fowler. 2005. Development of an adult-like cell-mediated immune response in calves after early vaccination with Mycobacterium bovis bacillus Calmette-Guérin. J. Dairy Sci. 88:195-210.
15. Olsen, S. C., M. G. Stevens, N. F. Cheville, and G. G. Schurig. 1997. Experimental use of a dot blot assay to measure serologic responses of cattle vaccinated with Brucella abortus strain RB51. J. Vet. Diagn. Investig. 9:363-367.
16. Olsen, S. C., T. J. Kreeger, and M. V. Palmer. 2002. Immune responses of elk to vaccination with Brucella abortus strain RB51. J. Wildl. Dis. 38:746-751.
17. Olsen, S. C., T. J. Kreeger, and W. Schultz. 2002. Immune responses of bison to ballistic or hand vaccination with Brucella abortus strain RB51. J. Wildl. Dis. 34:738-745.
18. Olsen, S. C., A. E. Jensen, W. C. Stoffregen, and M. V. Palmer. 2003. Efficacy of calfhood vaccination with Brucella abortus strain RB51 in protecting bison against brucellosis. Res. Vet. Sci. 74:17-22.
19. Rook, G. A. W., K. Dheda, and A. Zumla. 2006. Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. Tuberculosis 86:152-162.
20. Schurig, G. G., A. T. Pringle, and S. S. Breese. 1981. Localization of Brucella antigens that elicit a humoral immune response in Brucella abortus-infected cattle. Infect. Immun. 34:1000-1007.
21. Smith, B. L. 2001. Winter feeding of elk in Western North America. J. Wildl. Meet. 65:173-190.
22. Stevens, M. G., S. C. Olsen, and N. F. Cheville. 1995. Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or strain RB51. Vet. Immunol. Immunopathol. 44:223-235.
23. Thorne, E. T., T. J. Walthall, and H. A. Dawson. 1981. Vaccination of elk with strain 19 Brucella abortus. Proc. U. S. Anim. Health Assoc. 85:359-374.
24. Tunnicliff, E. A., and H. Marsh. 1935. Bang's disease in bison and elk in the Yellowstone National Park and on the National Bison Range. J. Am. Vet. Med. Assoc. 86:745-752.
25. Vemulappalli, R., J. R. Mcquiston, G. G. Schurig, N. Sriranganathan, S. M. Halling, and S. M. Boyle. 1999. Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains. Clin. Diagn. Lab. Immunol. 6:760-764.
26. Waters, W. R., M. V. Palmer, S. C. Olsen, R. E. Sacco, and D. L. Whipple. 2003. Immune responses of elk to Mycobacterium bovis bacillus Calmette Guerin vaccination. Vaccine 21:1518-1526.
27. Waters, W. R., M. V. Palmer, D. L. Whipple, R. E. Slaughter, and S. L. Jones. 2004. Immune responses of white-tailed deer (Odocoileus virginianus) to Mycobacterium bovis BCG vaccination. J. Wildl. Dis. 40:66-78.
28. Winter, A. J., G. E. Rowe., J. R. Duncan, M. J. Eise, J. Widom, B. Ganem, and B. Morein. 1988. Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice. Infect. Immun. 56:2808-2817.
29. Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance to Brucella abortus infections. Infect. Immun. 63:1387-1390.